Corcept Therapeutics
CORT
#2078
Rank
ยฃ6.81 B
Marketcap
ยฃ64.63
Share price
1.71%
Change (1 day)
38.79%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ4.77 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is ยฃ4.77 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ5.52 M4563.26%
2023-12-31ยฃ0.11 M-87.45%
2022-12-31ยฃ0.94 M142.45%
2021-12-31ยฃ0.38 M-79.18%
2020-12-31ยฃ1.87 M-29.09%
2019-12-31ยฃ2.63 M
2018-12-31N/A
2016-12-31ยฃ11.88 M17.68%
2015-12-31ยฃ10.09 M66.83%
2014-12-31ยฃ6.05 M73.86%
2013-12-31ยฃ3.48 M112.35%
2012-12-31ยฃ1.63 M
2010-12-31N/A-100%
2009-12-31ยฃ0 M-66.04%
2008-12-31ยฃ0.01 M-25.21%
2007-12-31ยฃ0.01 M-31.92%
2006-12-31ยฃ0.02 M-31.53%
2005-12-31ยฃ0.03 M
2003-12-31ยฃ0.29 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ34.37 B 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ38.31 B 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ24.03 B 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ31.90 B 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ45.67 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ31.05 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.23 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ90.01 M 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.45 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA